RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharmagreen Biotech Stock

Pharmagreen Biotech Revenue 2025

Pharmagreen Biotech Revenue

3,400 USD

Ticker

PHBI

ISIN

US71716C1099

WKN

A2NB5X

In 2025, Pharmagreen Biotech's sales reached 3,400 USD, a 13.33% difference from the 3,000 USD sales recorded in the previous year.

The Pharmagreen Biotech Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
20243.450,00
2023330,00
2022--
2021--
2020--
2019--
2018--
2017--

Pharmagreen Biotech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Pharmagreen Biotech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Pharmagreen Biotech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Pharmagreen Biotech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Pharmagreen Biotech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Pharmagreen Biotech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Pharmagreen Biotech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Pharmagreen Biotech’s growth potential.

Pharmagreen Biotech Revenue, EBIT and net profit per share

DatePharmagreen Biotech RevenuePharmagreen Biotech EBITPharmagreen Biotech Net Income
20243,400 undefined-248,200 undefined-1 M undefined
20233,000 undefined-474,000 undefined-568,800 undefined
20220 undefined-1.07 M undefined-875,500 undefined
20210 undefined-752,700 undefined-4.53 M undefined
20200 undefined-193,200 undefined-2.44 M undefined
20190 undefined-652,100 undefined-767,500 undefined
20180 undefined-663,200 undefined-1.07 M undefined
20170 undefined-563,300 undefined-608,200 undefined

Pharmagreen Biotech stock margins

The Pharmagreen Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pharmagreen Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pharmagreen Biotech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Pharmagreen Biotech's sales revenue. A higher gross margin percentage indicates that the Pharmagreen Biotech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Pharmagreen Biotech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Pharmagreen Biotech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Pharmagreen Biotech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Pharmagreen Biotech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Pharmagreen Biotech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Pharmagreen Biotech Margin History

Pharmagreen Biotech Gross marginPharmagreen Biotech Profit marginPharmagreen Biotech EBIT marginPharmagreen Biotech Profit margin
202450 %-7,300 %-29,541.18 %
202330 %-15,800 %-18,960 %
202250 %0 %0 %
202150 %0 %0 %
202050 %0 %0 %
201950 %0 %0 %
201850 %0 %0 %
201750 %0 %0 %

Pharmagreen Biotech Aktienanalyse

What does Pharmagreen Biotech do?

Pharmagreen Biotech Inc is a Canadian company specializing in the production of cannabis plants. The company was founded in 2009. Initially, the company focused primarily on research in the field of plant biotechnology. It worked on developing plants with higher cold resistance for cultivation in colder regions. Research in breeding plants with higher nutritional value was also part of their focus. In 2017, the company recognized the incredible potential of the cannabis industry and decided to apply its expertise in this field. Pharmagreen Biotech Inc began large-scale production of cannabis plants, working closely with other industry leaders to optimize production and create the best possible conditions. Pharmagreen Biotech Inc places great importance on sustainability and environmental awareness. All production methods are designed with ecological sustainability in mind. The plants are grown in environmentally-friendly greenhouses and all waste is recycled and reused. The business model of Pharmagreen Biotech Inc is tailored to the needs of its customers. The company produces cannabis plants for the medical and recreational sectors. It offers various types of plants to meet the needs of customers, including plants for home cultivation to cater to the growing market for self-grown cannabis plants. Products offered by Pharmagreen Biotech Inc also include seeds, fertilizers, and specialized cultivation kits tailored to the needs of cannabis plants. The company works closely with laboratories and research institutions to maximize and optimize the quality and potency of its products. The company recently developed a new technology called "Speed Breeding," which allows for the rapid breeding of cannabis plants. This enables Pharmagreen Biotech Inc to serve an even larger portion of the market and provide faster availability of products for customers. Pharmagreen Biotech Inc is divided into various divisions, including medical cannabis production, recreational cannabis, plant products, and seed production. Each division is led by a specialized team focused on the needs and requirements of customers in that area. Overall, Pharmagreen Biotech Inc is an innovative and sustainable company focused on the needs of its customers. Its wide range of products and ongoing research and development make it an important player in the rapidly growing cannabis industry. Pharmagreen Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Pharmagreen Biotech's Sales Figures

The sales figures of Pharmagreen Biotech originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Pharmagreen Biotech’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Pharmagreen Biotech's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Pharmagreen Biotech’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Pharmagreen Biotech stock

How much revenue did Pharmagreen Biotech generate this year?

Pharmagreen Biotech has achieved a revenue of 3,400 USD this year.

How much was the turnover of the company Pharmagreen Biotech compared to the previous year?

The revenue of Pharmagreen Biotech has increased by 13.33% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Pharmagreen Biotech?

The revenue of Pharmagreen Biotech is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Pharmagreen Biotech measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Pharmagreen Biotech so important for investors?

The revenue of Pharmagreen Biotech is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Pharmagreen Biotech pay?

Over the past 12 months, Pharmagreen Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmagreen Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Pharmagreen Biotech?

The current dividend yield of Pharmagreen Biotech is .

When does Pharmagreen Biotech pay dividends?

Pharmagreen Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmagreen Biotech?

Pharmagreen Biotech paid dividends every year for the past 0 years.

What is the dividend of Pharmagreen Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmagreen Biotech located?

Pharmagreen Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmagreen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmagreen Biotech from 7/24/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/24/2025.

When did Pharmagreen Biotech pay the last dividend?

The last dividend was paid out on 7/24/2025.

What was the dividend of Pharmagreen Biotech in the year 2024?

In the year 2024, Pharmagreen Biotech distributed 0 USD as dividends.

In which currency does Pharmagreen Biotech pay out the dividend?

The dividends of Pharmagreen Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharmagreen Biotech

Our stock analysis for Pharmagreen Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmagreen Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.